How would you approach treating a patient with active rheumatoid arthritis and a history of treated lymphoma that is currently in remission?
Given the controversy in the literature regarding TNFi or MTX associated lymphoma in patients with RA.
Answer from: at Academic Institution
I would individualize treatment in each patient depending on degree of RA activity, type of lymphoma and length of time of remission with shared decision-making between myself, patient and oncologist. For moderate to high degree of activity of RA, in general, rituximab in keeping with the ACR 2021 g...
Sign in or Register to read more